FOLH1 and prostate carcinoma: Furthermore, recent shreds of evidence highlighted PSMA overexpression in the neovasculature of various types of cancer other than prostate cancer, including clear cell renal carcinoma, thyroid cancer, and hepatocellular carcinoma [22,23,24].